Dr Benjamin Mullin is a postdoctoral scientist with experience in genetics, bioinformatics and molecular biology. He completed his PhD studies in the genetic epidemiology of osteoporosis at Curtin University in 2011. Dr Mullin is currently appointed as a Research Associate at the University of Western Australia (2012 - present). Prior to this he worked as a Medical Scientist in the Molecular Genetics Department at PathWest Laboratory Medicine (2010 – 2012).

Dr Mullin’s primary research interests focus on investigating the genetics of complex disease, particularly bone disease and reproductive endocrinology. He has worked on several genome-wide association studies (GWAS), including leading two international GWAS meta-analyses for bone structural phenotypes. Dr Mullin also recently played a leading role in the generation of a unique osteoclast-specific expression quantitative trait locus (eQTL) resource for study of the genetics of bone disease.

Dr Mullin has publications in The Lancet, Annals of Internal Medicine, Genome Biology, Nature Communications, the American Journal of Human Genetics, PLoS Genetics, Human Molecular Genetics and the Journal of Bone and Mineral Research (leading international bone journal). He is also a reviewer for the American Journal of Human Genetics, Epigenomics, Human Genetics, the Journal of Bone and Mineral Research, the Journal of Genetics and Genomics, The Journal of Clinical Endocrinology and Metabolism, Scientific Reports and Osteoporosis International. Dr Mullin’s work has been the subject of two media releases and he is named as a co-inventor in four provisional patent applications.